Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 38985-79-4 | MDL No. : | MFCD00040904 |
Formula : | C9H8BrNO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | QVABAFHRLMDDLM-UHFFFAOYSA-N |
M.W : | 258.07 | Pubchem ID : | 520935 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.11 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 55.41 |
TPSA : | 66.4 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.05 cm/s |
Log Po/w (iLOGP) : | 1.42 |
Log Po/w (XLOGP3) : | 2.57 |
Log Po/w (WLOGP) : | 1.91 |
Log Po/w (MLOGP) : | 1.83 |
Log Po/w (SILICOS-IT) : | 1.48 |
Consensus Log Po/w : | 1.84 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -3.18 |
Solubility : | 0.171 mg/ml ; 0.000663 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.61 |
Solubility : | 0.063 mg/ml ; 0.000244 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.02 |
Solubility : | 0.249 mg/ml ; 0.000966 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 1.6 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313 | UN#: | N/A |
Hazard Statements: | H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 101861-53-4 ]
4-Bromo-2-acetamidobenzoic acid
Similarity: 0.96
[ 82762-56-9 ]
5-Bromo-2-(ethylamino)benzoic acid
Similarity: 0.92
[ 1248924-55-1 ]
5-Bromo-2-formamidobenzoic acid
Similarity: 0.92
[ 138825-96-4 ]
Methyl 2-acetamido-5-bromobenzoate
Similarity: 0.91
[ 73721-76-3 ]
5-Bromo-2-butyramidobenzoic acid
Similarity: 0.91
[ 101861-53-4 ]
4-Bromo-2-acetamidobenzoic acid
Similarity: 0.96
[ 82762-56-9 ]
5-Bromo-2-(ethylamino)benzoic acid
Similarity: 0.92
[ 1248924-55-1 ]
5-Bromo-2-formamidobenzoic acid
Similarity: 0.92
[ 138825-96-4 ]
Methyl 2-acetamido-5-bromobenzoate
Similarity: 0.91
[ 73721-76-3 ]
5-Bromo-2-butyramidobenzoic acid
Similarity: 0.91
[ 101861-53-4 ]
4-Bromo-2-acetamidobenzoic acid
Similarity: 0.96
[ 138825-96-4 ]
Methyl 2-acetamido-5-bromobenzoate
Similarity: 0.91
[ 73721-76-3 ]
5-Bromo-2-butyramidobenzoic acid
Similarity: 0.91
[ 78238-11-6 ]
3-Acetamido-5-bromobenzoic acid
Similarity: 0.89
[ 1845698-44-3 ]
5-Acetamido-2-bromo-4-methylbenzoic acid
Similarity: 0.88
[ 101861-53-4 ]
4-Bromo-2-acetamidobenzoic acid
Similarity: 0.96
[ 82762-56-9 ]
5-Bromo-2-(ethylamino)benzoic acid
Similarity: 0.92
[ 1248924-55-1 ]
5-Bromo-2-formamidobenzoic acid
Similarity: 0.92
[ 138825-96-4 ]
Methyl 2-acetamido-5-bromobenzoate
Similarity: 0.91
[ 73721-76-3 ]
5-Bromo-2-butyramidobenzoic acid
Similarity: 0.91
[ 101861-53-4 ]
4-Bromo-2-acetamidobenzoic acid
Similarity: 0.96
[ 82762-56-9 ]
5-Bromo-2-(ethylamino)benzoic acid
Similarity: 0.92
[ 1248924-55-1 ]
5-Bromo-2-formamidobenzoic acid
Similarity: 0.92
[ 73721-76-3 ]
5-Bromo-2-butyramidobenzoic acid
Similarity: 0.91
[ 78238-11-6 ]
3-Acetamido-5-bromobenzoic acid
Similarity: 0.89